Pfizer Branches Out with Stem Cell Therapy Investment

Melly Alazraki

With each passing day, old-line drug company Pfizer (PFE), the name behind cholesterol-lowering drug Lipitor and erectile-dysfunction treatment Viagra, is acting increasingly like a young biotech firm. The latest development? New York-based Pfizer is licensing a new stem cell therapy for inflammatory bowel disease biotech firm Athersys (ATHX), the Cleveland, Ohio-based company said.

  • DJI30996.98-179.03-0.57%
    NASDAQ13543.0612.150.09%
    S&P 5003841.47-11.60-0.30%
  • NIKKEI 22528631.45-125.41-0.44%
    Hang Seng29447.85-479.91-1.60%
    DAX13873.97-32.70-0.24%
  • USD (PER EUR)1.220.00010.01%
    USD (PER CHF)1.130.00010.01%
    JPY (PER USD)103.760.25600.25%
    GBP (PER USD)1.37-0.0046-0.34%